搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 天
诺和诺德股价重挫近6%!减肥口服药试验结果喜忧参半
财联社9月20日讯(编辑 赵昊)周五(9月20日)美股早盘,丹麦制药巨头诺和诺德股价跌近6%,日内最低报每股126.13美元,为8月9日以来的最低水平。 诺和诺德股价日线图 消息面上,诺和诺德在官网发布了药物“monlunabant”2a期临床试验的主要结果。整体来看,与安慰剂相比,该药物具有显著统计学意义的体重减轻。但在较高剂量的组别中,体重额外减轻的效果有限。 据了解,monlunabant是 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Alabama mass shooting
Visits US ammunition plant
Daylight saving time
Dolphins legend Morris dies
No govt. shutdown for now
California plastic bag ban
Economic speech this week
Israeli strikes in Lebanon
Trump to campaign in MI
Robinson loses key staff
Ga. suspect's mom indicted
San Francisco homelessness
Released after guilty plea
No. 1 at box office again
Free COVID-19 tests
Donlon's homes searched
Former WA governor dies
J&J unit files for bankruptcy
TN abortion law blocked
ISR raids Al Jazeera office
Drug price challenge revived
Boeing defense chief exits
CA bill to protect kids online
Biden hosts 'Quad' summit
CA firefighter held for arson
Suns broadcaster dies
SC 1st execution in 13 years
Iran coal mine blast
Sesame Place suit verdict
PM Modi visits US
反馈